Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024 - Takeaways - MDSpire

Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024

  • By

  • Alain Bernard

  • Jonathan Cottenet

  • Pascale Tubert-Bitter

  • Catherine Quantin

  • June 22, 2026

  • 0 min

Share

  • 1

    This study analyzes lung cancer surgery performance across 148 French hospitals from 2020 to 2024, involving 56,299 patients.

  • 2

    Severe complications occurred in 15%–40% of cases, with 2%–5% mortality, highlighting significant interhospital variability.

  • 3

    Medium-volume hospitals showed optimal improvement trajectories with a 45% reduction in risk-adjusted complications.

  • 4

    Some low-volume hospitals experienced a catastrophic 843% increase in complication rates, while a subgroup of high-volume hospitals also deteriorated.

  • 5

    The study suggests that surgical volume alone does not guarantee quality, emphasizing the importance of organizational factors and continuous feedback.

Original Source(s)

Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024

  • by Alain Bernard, Jonathan Cottenet, Pascale Tubert-Bitter, Catherine Quantin

  • June 22, 2026

Related Content

Short-term quantitative CT changes in synchronous ground-glass nodules during immune checkpoint inhibitor therapy in patients with lung cancer

Case Report: immune checkpoint inhibitor-associated aseptic meningitis in lung cancer: two cases illustrating an exclusion-based diagnosis approach and stepwise immunosuppressive treatment

Metastatic progression and treatment challenges in EBV-associated pulmonary lymphoepithelioma-like carcinoma: a case report